Alzheimer's disease remains one of the greatest societal and economic challenges of our time. It is estimated that there are over six (6) million people living with Alzheimer’s Disease in the US, and this number is expected to double by 2050.
Monument Biosciences is dedicated to bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). Our team is comprised of leading neuro focused scientists, clinicians, and entrepreneurs.
We are here to advance a new generation of AD targets that push the frontiers of research that can translate to meaningful improvements in lives of patients and their families.
To accomplish that vision we are exploring diverse therapeutic modalities and potential combination therapy – what we believe to be the future of research and patient care in ADRD and neurodegeneration.
